https://pharmadog.xyz/news/569007 pharmadog en 2026-10-20T17:57:40.000Z ICER report finds median launch drug prices jumped 24% between 2022 and 2025 https://pharmadog.xyz/news/568883 pharmadog en 2026-10-20T16:47:02.000Z Lawmakers push FDA to close loophole allowing import of counterfeit Eli Lilly obesity drug https://pharmadog.xyz/news/568884 pharmadog en 2026-10-20T16:42:06.000Z Roche signs major partnership with China's Hansoh to co-develop antibody-drug conjugates https://pharmadog.xyz/news/568903 pharmadog en 2026-10-20T16:27:00.000Z Rapport Therapeutics' epilepsy drug RAP-219 meets primary endpoint in bipolar mania Phase II trial https://pharmadog.xyz/news/568922 pharmadog en 2026-10-20T15:57:36.000Z FDA approves first generic weekly hormone patch for menopausal women https://pharmadog.xyz/news/568904 pharmadog en 2026-10-20T15:55:00.000Z ICER reports two-thirds of new drugs launched 2022-2025 priced well above cost-effectiveness thresholds https://pharmadog.xyz/news/568715 pharmadog en 2026-10-20T15:41:10.000Z Reporter urges audiences to skip new Elizabeth Holmes documentary https://pharmadog.xyz/news/568563 pharmadog en 2026-10-20T15:15:18.000Z Epic introduces prescription marketplace to let doctors and patients compare drug prices https://pharmadog.xyz/news/568395 pharmadog en 2026-10-20T14:55:11.000Z Pfizer halts Phase 2 trial of PF-06835375 in primary immune thrombocytopenia https://pharmadog.xyz/news/568439 pharmadog en 2026-10-20T14:40:13.000Z JAMA paper on OpenEvidence highlights clinician use but raises unanswered questions https://pharmadog.xyz/news/568440 pharmadog en 2026-10-20T14:02:16.000Z Median net price of new drugs jumps 35% from 2022 to 2025, reaching $257,000 https://pharmadog.xyz/news/568419 pharmadog en 2026-10-20T14:00:59.000Z Rapport Therapeutics reports Phase 2 success for RAP-219 in bipolar mania trial https://pharmadog.xyz/news/568227 pharmadog en 2026-10-20T13:49:20.000Z Biopharma Sentiment Index climbs to upbeat 105 in Q3 2026, marking strongest optimism in years https://pharmadog.xyz/news/134233 pharmadog en 2026-10-20T13:43:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/568252 pharmadog en 2026-10-20T13:40:12.000Z BioSpace podcast highlights Q3 job market gains and sharp layoff decline for biopharma talent https://pharmadog.xyz/news/568310 pharmadog en 2026-10-20T13:03:14.000Z FDA releases final guidance on prescription-drug companion apps and software https://pharmadog.xyz/news/568103 pharmadog en 2026-10-20T12:55:52.000Z New poll gauges U.S. voter attitudes toward transgender sports participation and abortion access https://pharmadog.xyz/news/568253 pharmadog en 2026-10-20T12:54:15.000Z Lilly commits up to $1.1 billion to Hong Kong biotech METiS TechBio's AI-driven lipid nanoparticle platform https://pharmadog.xyz/news/568104 pharmadog en 2026-10-20T12:37:18.000Z Dana-Farber and Beth Israel Lahey Health break ground on $1.68 billion cancer hospital in Boston https://pharmadog.xyz/news/568059 pharmadog en 2026-10-20T12:00:46.000Z Astellas teams up with Boston miniprotein startup to explore AI-designed tiny proteins https://pharmadog.xyz/news/568123 pharmadog en 2026-10-20T12:00:00.000Z Pharma pours billions into bispecifics, ADCs and cell therapies despite limited clinical proof https://pharmadog.xyz/news/568084 pharmadog en 2026-10-20T11:56:15.000Z Gilead’s emvistegrast shows superior response to placebo in Phase 2 ulcerative colitis trial https://pharmadog.xyz/news/567891 pharmadog en 2026-10-20T11:14:39.000Z Rapport Therapeutics reports Phase 2 success for J&J-licensed bipolar mania drug https://pharmadog.xyz/news/567767 pharmadog en 2026-10-20T10:30:00.000Z New drug launch prices climb 35% to $257,000 median, with a quarter exceeding $500,000 https://pharmadog.xyz/news/568202 pharmadog en 2026-10-20T09:20:00.000Z Rapport Therapeutics' Phase 2 Bipolar Mania Trial Meets Primary Endpoint, Though Effect Size Below Target https://pharmadog.xyz/news/567324 pharmadog en 2026-10-20T08:30:00.000Z Proposed ACGME rule changes could strip resident doctors of mandatory rest periods https://pharmadog.xyz/news/567323 pharmadog en 2026-10-20T08:30:00.000Z Midterm ballot measures spotlight abortion, transgender rights and Medicaid expansion https://pharmadog.xyz/news/568370 pharmadog en 2026-10-20T07:50:00.000Z Lycia Therapeutics targets $228M IPO to fund food allergy protein degrader programs https://pharmadog.xyz/news/566968 pharmadog en 2026-10-20T06:00:00.000Z BioSpace releases Q3 2026 biopharma job market report showing upbeat hiring trends https://pharmadog.xyz/news/568817 pharmadog en 2026-10-20T04:44:00.000Z EY report says MedTech growth driven by commercial leaders, AI and expanding into new care settings https://pharmadog.xyz/news/538247 pharmadog en 2026-10-20T04:29:00.000Z Alnylam shares tumble to $250 after cutting full-year revenue guidance for its TTR franchise https://pharmadog.xyz/news/566525 pharmadog en 2026-10-20T04:15:00.000Z Genmab faces steep revenue cliff as Darzalex patents expire, eyes pivotal Epkinly readout https://pharmadog.xyz/news/567254 pharmadog en 2026-10-20T04:03:00.000Z Pfizer halts phase 2 trial of CXCR5 antibody for immune thrombocytopenia https://pharmadog.xyz/news/569110 pharmadog en 2026-10-20T04:00:00.000Z Cardinal Health issues updated instructions for Presource kits containing recalled BD Alaris infusion sets https://pharmadog.xyz/news/568942 pharmadog en 2026-10-20T04:00:00.000Z Nova Biomedical pulls Gen 2.0 StatStrip hospital glucose meters over patient ID software flaw https://pharmadog.xyz/news/566918 pharmadog en 2026-10-20T02:37:00.000Z AstraZeneca partners with Oracle to boost clinical trial patient recruitment using AI https://pharmadog.xyz/news/564771 pharmadog en 2026-10-19T19:17:01.000Z Massachusetts jury awards former MIT professor David Sabatini $6 million in defamation case https://pharmadog.xyz/news/564772 pharmadog en 2026-10-19T19:01:09.000Z Antheia secures $80 million conditional loan from DOD to expand U.S. generic drug manufacturing https://pharmadog.xyz/news/564479 pharmadog en 2026-10-19T17:42:45.000Z Trump signs executive order to create NIH division and White House task force for women’s health https://pharmadog.xyz/news/564459 pharmadog en 2026-10-19T17:42:23.000Z Sanofi breaks ground on Frankfurt insulin API plant with €400 million German aid https://pharmadog.xyz/news/564371 pharmadog en 2026-10-19T17:27:04.000Z Theranos whistleblower says new film ‘You Can See Everything’ is art, not a documentary https://pharmadog.xyz/news/564327 pharmadog en 2026-10-19T17:03:24.000Z ESMO 2026 preview spotlights upcoming abstracts from Zai Lab, GSK and Merck https://pharmadog.xyz/news/564183 pharmadog en 2026-10-19T16:43:59.000Z EyePoint cuts half its staff and ends wet AMD trials after second Phase 3 failure, pivots to diabetic macular edema https://pharmadog.xyz/news/564223 pharmadog en 2026-10-19T16:27:00.000Z Disc Medicine reports positive Phase 3 results for bitopertin in erythropoietic porphyria https://pharmadog.xyz/news/564242 pharmadog en 2026-10-19T16:19:38.000Z FDA Grants Accelerated Approval for Jemperli Immunotherapy in Locally Advanced Rectal Cancer https://pharmadog.xyz/news/564035 pharmadog en 2026-10-19T15:43:35.000Z Arbitrators profit heavily from No Surprises Act disputes, raising concerns over health-care billing practices https://pharmadog.xyz/news/564015 pharmadog en 2026-10-19T15:17:26.000Z Merck KGaA to acquire Silence Therapeutics for $1.1 billion, gaining Phase 3 PV siRNA asset https://pharmadog.xyz/news/563991 pharmadog en 2026-10-19T15:05:39.000Z Gilead to launch Phase 3 trial of oral α4β7 inhibitor after promising Phase 2 ulcerative colitis results https://pharmadog.xyz/news/563992 pharmadog en 2026-10-19T15:01:30.000Z EyePoint's Phase 3 trial fails, prompting 53% staff cuts; Lilly signs China drug delivery partnership https://pharmadog.xyz/news/563867 pharmadog en 2026-10-19T14:58:31.000Z China proposes new limits on foreign biotech acquisitions to protect domestic drug development https://pharmadog.xyz/news/563847 pharmadog en 2026-10-19T14:30:28.000Z Roche signs $15 billion ADC partnership with China's Hansoh, offering $400 million upfront https://pharmadog.xyz/news/564224 pharmadog en 2026-10-19T13:59:52.000Z Merck KGaA to acquire Silence Therapeutics for $1.3 billion, adding Phase-2 RNAi drug for polycythemia vera https://pharmadog.xyz/news/563655 pharmadog en 2026-10-19T13:57:45.000Z Merck KGaA to acquire Silence Therapeutics for $1.3 billion, expanding siRNA portfolio https://pharmadog.xyz/news/563848 pharmadog en 2026-10-19T13:57:01.000Z China proposes ban on biotech platform sales but keeps licensing deals open https://pharmadog.xyz/news/563699 pharmadog en 2026-10-19T13:39:28.000Z Former GOP lawmakers warn that confusing vaccine messaging could hurt party's midterm prospects https://pharmadog.xyz/news/563700 pharmadog en 2026-10-19T13:23:58.000Z FDA forms new board to guide drug exclusivity decisions as Roche reexamines German investments https://pharmadog.xyz/news/563679 pharmadog en 2026-10-19T13:17:00.000Z Novartis halts Phase 2 lupus nephritis trial of Fabhalta, cites strategic reasons https://pharmadog.xyz/news/564055 pharmadog en 2026-10-19T13:14:00.000Z Roche signs up to $15 billion ADC partnership with China's Hansoh, paying $400 million upfront https://pharmadog.xyz/news/563656 pharmadog en 2026-10-19T13:00:41.000Z Sanofi partners with ScionxBio to screen long-acting RNA candidates https://pharmadog.xyz/news/563319 pharmadog en 2026-10-19T11:08:33.000Z Roche signs $400 million upfront deal with China's Hansoh, potential $15 billion partnership https://pharmadog.xyz/news/563343 pharmadog en 2026-10-19T11:02:00.000Z Disc Medicine reports positive Phase 3 results for bitopertin in erythropoietic protoporphyria, setting stage for FDA resubmission https://pharmadog.xyz/news/563344 pharmadog en 2026-10-19T11:01:00.000Z Veradermics reports Phase 3 minoxidil pill boosts hair coverage in men https://pharmadog.xyz/news/563211 pharmadog en 2026-10-19T11:00:36.000Z Disc Medicine's rare sun-sensitivity drug meets all endpoints in Phase 3 trial https://pharmadog.xyz/news/563213 pharmadog en 2026-10-19T11:00:09.000Z Veradermics' oral minoxidil clears late-stage trial endpoints https://pharmadog.xyz/news/563212 pharmadog en 2026-10-19T11:00:09.000Z TriGemX Bio to go public via SPAC to advance migraine drug candidate https://pharmadog.xyz/news/563798 pharmadog en 2026-10-19T10:46:00.000Z Eli Lilly teams with Hong Kong's Metis TechBio in up to $1.1 billion AI nanoparticle partnership https://pharmadog.xyz/news/563966 pharmadog en 2026-10-19T10:34:00.000Z TCGX uses SPAC to take migraine biotech TriGemX public, securing $246M for phase-3 trial https://pharmadog.xyz/news/563969 pharmadog en 2026-10-19T09:48:00.000Z Gilead reports positive Phase 2 results for oral ulcerative colitis drug https://pharmadog.xyz/news/563630 pharmadog en 2026-10-19T09:44:00.000Z Enlivex cuts 60% of staff, halts preclinical R&D and slashes exec salaries to fund osteoarthritis trial https://pharmadog.xyz/news/563631 pharmadog en 2026-10-19T09:00:00.000Z Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win https://pharmadog.xyz/news/562939 pharmadog en 2026-10-19T09:00:00.000Z Saudi Arabia rolls out biotech partnerships to support its $34.6 billion non‑oil growth plan https://pharmadog.xyz/news/562940 pharmadog en 2026-10-19T09:00:00.000Z Study shows low extractables in single-use components support ADC manufacturing https://pharmadog.xyz/news/562941 pharmadog en 2026-10-19T09:00:00.000Z Early CDMO engagement: balancing speed with flexibility in CMC planning https://pharmadog.xyz/news/562751 pharmadog en 2026-10-19T08:35:00.000Z Gilead’s oral ulcerative colitis drug shows significant remission in Phase 2 trial https://pharmadog.xyz/news/562754 pharmadog en 2026-10-19T08:30:00.000Z Editor shares personal loss and calls for assisted suicide options for severe mental illness https://pharmadog.xyz/news/562756 pharmadog en 2026-10-19T08:30:00.000Z Nonprofit arbitrators under No Surprises Act earning large profits, investigation finds https://pharmadog.xyz/news/562753 pharmadog en 2026-10-19T08:30:00.000Z Alphabet’s Isomorphic Labs draws VC interest as it seeks to turn AI protein modeling into drug discovery engine https://pharmadog.xyz/news/562752 pharmadog en 2026-10-19T08:30:00.000Z Immunology Society Split Over California’s $8.4 B Proposition 38 Funding Measure https://pharmadog.xyz/news/562755 pharmadog en 2026-10-19T08:30:00.000Z Measles resurgence threatens Republican midterm prospects, physicians warn https://pharmadog.xyz/news/563632 pharmadog en 2026-10-19T08:00:00.000Z Disc spins past FDA rejection with ‘overwhelmingly positive’ phase 3 data for rare disease drug https://pharmadog.xyz/news/563467 pharmadog en 2026-10-19T07:49:00.000Z Roche signs $15 billion ADC partnership with China's Hansoh Pharma https://pharmadog.xyz/news/562371 pharmadog en 2026-10-19T06:00:32.000Z Nouscom secures $135 million Series D to advance lead cancer vaccine into Phase 2 https://pharmadog.xyz/news/563018 pharmadog en 2026-10-19T05:16:00.000Z AbbVie’s combo of Skyrizi and trosunilimab shows higher remission than Skyrizi alone in phase 2 Crohn’s trial https://pharmadog.xyz/news/562119 pharmadog en 2026-10-19T05:00:00.000Z Sino Biological offers validated cytokines to improve organoid culture and research https://pharmadog.xyz/news/567866 pharmadog en 2026-10-19T04:28:00.000Z Israeli biotech's inhaled exosome therapy cuts respiratory failure and mortality in ARDS phase 2b trial https://pharmadog.xyz/news/561951 pharmadog en 2026-10-19T04:18:00.000Z Merck/Moderna vaccine and Summit/Akeso bispecific therapy among key highlights at ESMO 2026 https://pharmadog.xyz/news/561952 pharmadog en 2026-10-19T04:02:00.000Z Experts tout amylin as promising, potentially gentler obesity target as new combo therapies near FDA review https://pharmadog.xyz/news/561953 pharmadog en 2026-10-19T04:01:00.000Z Multispecific drug design faces growing complexity as more binding arms increase molecular options https://pharmadog.xyz/news/564874 pharmadog en 2026-10-19T04:00:00.000Z Philips issues updated use instructions for Lumify ultrasound systems after software glitch risk https://pharmadog.xyz/news/563466 pharmadog en 2026-10-19T02:22:00.000Z Siemens Healthineers teams with Paradromics to develop multimodal imaging platform for brain-computer interfaces https://pharmadog.xyz/news/561299 pharmadog en 2026-10-19T00:54:03.000Z Cambridge biologist David Sabatini awarded $6 million after jury rejects harassment claims https://pharmadog.xyz/news/565459 pharmadog en 2026-10-19T00:00:00.000Z Merck acquires Silence Therapeutics for $1.3B; Hansoh Pharma signs $15B deal with Roche https://pharmadog.xyz/news/565458 pharmadog en 2026-10-19T00:00:00.000Z Japan’s PMDA releases guidance on evaluating generative AI-enabled medical devices https://pharmadog.xyz/news/565457 pharmadog en 2026-10-19T00:00:00.000Z MedTech firms grow more comfortable with FDA's Quality Management System Regulation amid inspection concerns